Apollo Medical Holdings Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $31.52
- Today's High:
- $33.06
- Open Price:
- $32.98
- 52W Low:
- $26.89
- 52W High:
- $58
- Prev. Close:
- $33.2
- Volume:
- 191255
Company Statistics
- Market Cap.:
- $1.69 billion
- Book Value:
- 11.869
- Revenue TTM:
- $1.14 billion
- Operating Margin TTM:
- 9.11%
- Gross Profit TTM:
- $199.48 million
- Profit Margin:
- 4.29%
- Return on Assets TTM:
- 7.18%
- Return on Equity TTM:
- 9.32%
Company Profile
Apollo Medical Holdings Inc had its IPO on 2000-01-13 under the ticker symbol AMEH.
The company operates in the Healthcare sector and Medical Care Facilities industry. Apollo Medical Holdings Inc has a staff strength of 1,362 employees.
Stock update
Shares of Apollo Medical Holdings Inc opened at $32.98 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $31.52 - $33.06, and closed at $31.65.
This is a -4.67% slip from the previous day's closing price.
A total volume of 191,255 shares were traded at the close of the day’s session.
In the last one week, shares of Apollo Medical Holdings Inc have slipped by -16.49%.
Apollo Medical Holdings Inc's Key Ratios
Apollo Medical Holdings Inc has a market cap of $1.69 billion, indicating a price to book ratio of 2.5556 and a price to sales ratio of 1.1842.
In the last 12-months Apollo Medical Holdings Inc’s revenue was $1.14 billion with a gross profit of $199.48 million and an EBITDA of $121.81 million. The EBITDA ratio measures Apollo Medical Holdings Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Apollo Medical Holdings Inc’s operating margin was 9.11% while its return on assets stood at 7.18% with a return of equity of 9.32%.
In Q4, Apollo Medical Holdings Inc’s quarterly earnings growth was a negative -24.3% while revenue growth was a positive 50.8%.
Apollo Medical Holdings Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 33.4112
- PEG
- 0
Its diluted EPS in the last 12-months stands at $1.07 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Apollo Medical Holdings Inc’s profitability.
Apollo Medical Holdings Inc stock is trading at a EV to sales ratio of 1.2615 and a EV to EBITDA ratio of 16.7939. Its price to sales ratio in the trailing 12-months stood at 1.1842.
Apollo Medical Holdings Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $963.91 million
- Total Liabilities
- $147.33 million
- Operating Cash Flow
- $13.20 million
- Capital Expenditure
- $886000
- Dividend Payout Ratio
- 0%
Apollo Medical Holdings Inc ended 2024 with $963.91 million in total assets and $0 in total liabilities. Its intangible assets were valued at $963.91 million while shareholder equity stood at $555.01 million.
Apollo Medical Holdings Inc ended 2024 with $3.04 million in deferred long-term liabilities, $147.33 million in other current liabilities, 47000.00 in common stock, $192.68 million in retained earnings and $275.68 million in goodwill. Its cash balance stood at $288.03 million and cash and short-term investments were $293.59 million. The company’s total short-term debt was $4,785,000 while long-term debt stood at $203.39 million.
Apollo Medical Holdings Inc’s total current assets stands at $435.14 million while long-term investments were $40.30 million and short-term investments were $5.57 million. Its net receivables were $56.64 million compared to accounts payable of $49.56 million and inventory worth $0.
In 2024, Apollo Medical Holdings Inc's operating cash flow was $13.20 million while its capital expenditure stood at $886000.
Comparatively, Apollo Medical Holdings Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $31.65
- 52-Week High
- $58
- 52-Week Low
- $26.89
- Analyst Target Price
- $49
Apollo Medical Holdings Inc stock is currently trading at $31.65 per share. It touched a 52-week high of $58 and a 52-week low of $58. Analysts tracking the stock have a 12-month average target price of $49.
Its 50-day moving average was $35.43 and 200-day moving average was $34.14 The short ratio stood at 27.9 indicating a short percent outstanding of 0%.
Around 2853.9% of the company’s stock are held by insiders while 3522.1% are held by institutions.
Frequently Asked Questions About Apollo Medical Holdings Inc
Similar Industry Stocks (Medical Care Facilities)
Most Active
Top Gainers
Top Losers
About
Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services in the United States. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company’s physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was incorporated in 1985 and is headquartered in Alhambra, California.